Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chrysin loaded lipid-core nanocapsules ameliorates neurobehavioral alterations induced by β-amyloid1-42 in aged female mice
Renata Giacomeli, Marcelo Gomes de Gomes, Jéssica Brandão Reolon, et al.
Behavioural Brain Research (2020) Vol. 390, pp. 112696-112696
Closed Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Targeting apoptosis and autophagy following spinal cord injury: Therapeutic approaches to polyphenols and candidate phytochemicals
Fatemeh Abbaszadeh, Sajad Fakhri, Haroon Khan
Pharmacological Research (2020) Vol. 160, pp. 105069-105069
Closed Access | Times Cited: 108
Natural Phytochemicals as Novel Therapeutic Strategies to Prevent and Treat Parkinson’s Disease: Current Knowledge and Future Perspectives
Rengasamy Balakrishnan, Shofiul Azam, Duk-Yeon Cho, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 59
An updated review on the versatile role of chrysin in neurological diseases: Chemistry, pharmacology, and drug delivery approaches
Marjan Talebi, Mohsen Talebi, Tahereh Farkhondeh, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 141, pp. 111906-111906
Open Access | Times Cited: 59
Developing nutritional component chrysin as a therapeutic agent: Bioavailability and pharmacokinetics consideration, and ADME mechanisms
Song Gao, Nyma Siddiqui, Imoh Etim, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 142, pp. 112080-112080
Open Access | Times Cited: 59
Neuroprotective Potential of Chrysin: Mechanistic Insights and Therapeutic Potential for Neurological Disorders
Awanish Mishra, Pragya Shakti Mishra, Ritam Bandopadhyay, et al.
Molecules (2021) Vol. 26, Iss. 21, pp. 6456-6456
Open Access | Times Cited: 57
Protective Effects of Flavonoids against Alzheimer’s Disease: Pathological Hypothesis, Potential Targets, and Structure–Activity Relationship
Jiao Li, Min Sun, Xiaodong Cui, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 10020-10020
Open Access | Times Cited: 40
Core–Shell Type Lipidic and Polymeric Nanocapsules: the Transformative Multifaceted Delivery Systems
Arti Mehandole, Nikita Walke, Srushti Mahajan, et al.
AAPS PharmSciTech (2023) Vol. 24, Iss. 1
Closed Access | Times Cited: 22
Development of dietary small molecules as multi-targeting treatment strategies for Alzheimer's disease
Rengasamy Balakrishnan, Khoshnur Jannat, Dong‐Kug Choi
Redox Biology (2024) Vol. 71, pp. 103105-103105
Open Access | Times Cited: 11
Lipid shell lipid nanocapsules as smart generation lipid nanocarriers
Neha Dabholkar, Tejashree Waghule, Vamshi Krishna Rapalli, et al.
Journal of Molecular Liquids (2021) Vol. 339, pp. 117145-117145
Closed Access | Times Cited: 52
Natural polyphenol: Their pathogenesis-targeting therapeutic potential in Alzheimer's disease
Chengu Niu, Miaoxian Dong, Yingcai Niu
European Journal of Medicinal Chemistry (2024) Vol. 269, pp. 116359-116359
Closed Access | Times Cited: 7
Chrysin and Gallic Acid Protect the Hippocampal Neurons and Mitigate Blood-Brain Barrier Disruption in a Mouse Model of Global Cerebral Ischemia
Ali Vakili, Shahein Momenabadi, Ahmad Reza Bandegi, et al.
Jundishapur Journal of Natural Pharmaceutical Products (2025) Vol. 20, Iss. 1
Open Access
Poly lactic-co‐glycolic acid enhances the efficacy of the phytomedicine chrysin against cisplatin induced toxicity in submandibular salivary glands
Samah K. Ezzat, Hend Mohamed Anter, Ola A. Habotta, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Effects of Alpinae Oxyphyllae Fructus on microglial polarization in a LPS-induced BV2 cells model of neuroinflammation via TREM2
Mengjie Xu, Yunfang Yang, Jing Peng, et al.
Journal of Ethnopharmacology (2022) Vol. 302, pp. 115914-115914
Closed Access | Times Cited: 18
Therapeutic potential of flavonoids used in traditional Chinese medicine – a comparative study of galangin, kaempferol, chrysin and fisetin
Arkadiusz Sokal, Klaudia Stocerz, Paweł Olczyk, et al.
Annales Academiae Medicae Silesiensis (2024) Vol. 78, pp. 49-60
Open Access | Times Cited: 3
Therapeutic nanotechnologies for Alzheimer’s disease: A critical analysis of recent trends and findings
Philippe Delbreil, Jean‐Michel Rabanel, Xavier Banquy, et al.
Advanced Drug Delivery Reviews (2022) Vol. 187, pp. 114397-114397
Closed Access | Times Cited: 15
Karaya/Gellan-Gum-Based Bilayer Films Containing 3,3′-Diindolylmethane-Loaded Nanocapsules: A Promising Alternative to Melanoma Topical Treatment
Jéssica Brandão Reolon, Camila Parcianello Saccol, Bárbara Felin Osmari, et al.
Pharmaceutics (2023) Vol. 15, Iss. 9, pp. 2234-2234
Open Access | Times Cited: 8
Assessment of suberoylanilide hydroxamic acid on a Alzheimer's disease model induced by β-amyloid(1-42) in aged female mice: Neuromodulatory and epigenetic effect
Kellen Mariane Athaide Rocha, Franciéle Romero Machado, Márcia Rósula Poetini, et al.
Chemico-Biological Interactions (2023) Vol. 375, pp. 110429-110429
Closed Access | Times Cited: 7
New curcumin-loaded nanocapsules as a therapeutic alternative in an amnesia model
Karline da Costa Rodrigues, Manoel Rodrigues da Silva Neto, Víctor dos Santos Barboza, et al.
Metabolic Brain Disease (2024) Vol. 39, Iss. 4, pp. 589-609
Open Access | Times Cited: 2
Chrysin flavonoid encapsulation: a review about methodologies used and biological potential
Carlos Borges Filho, Marcelo Gomes de Gomes, Magali Kemmerich, et al.
Ciência Rural (2023) Vol. 54, Iss. 3
Open Access | Times Cited: 6
Potential therapeutic activities and novel delivery systems of chrysin-a nature’s boon
Shreya Chitrakant Adangale, Sarika Wairkar
Food Bioscience (2021) Vol. 45, pp. 101316-101316
Closed Access | Times Cited: 15
Possible mechanisms involved in the neuroprotective effects of chrysin against mild traumatic brain injury-induced spatial cognitive decline: An in vivo study in a rat model
Masome Rashno, Alireza Sarkaki, Yaghoob Farbood, et al.
Brain Research Bulletin (2023) Vol. 204, pp. 110779-110779
Open Access | Times Cited: 5
Neuroprotection induced by chrysin
Ana Flávia Furian, Lucian Del Fabbro, Marcelo Gomes de Gomes, et al.
Elsevier eBooks (2024), pp. 1363-1381
Closed Access | Times Cited: 1
Deciphering the multi-functional role of Indian propolis for the management of Alzheimer’s disease by integrating LC–MS/MS, network pharmacology, molecular docking, and in-vitro studies
S. N. Sankaran, Rahul Dubey, Anish Gomatam, et al.
Molecular Diversity (2024)
Closed Access | Times Cited: 1
A critical appraisal of geroprotective activities of flavonoids in terms of their bio-accessibility and polypharmacology
R Naskar, Anirrban Ghosh, Raja Bhattacharya, et al.
Neurochemistry International (2024) Vol. 180, pp. 105859-105859
Closed Access | Times Cited: 1
Dietary Flavonoid Chrysin Functions as a Dual Modulator to Attenuate Amyloid-β and Tau Pathology in the Models of Alzheimer’s Disease
Zhen Zhang, Rongyao Li, Yue Zhou, et al.
Molecular Neurobiology (2024) Vol. 62, Iss. 4, pp. 4274-4291
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top